Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients

Tohoku Journal of Experimental Medicine

Volumn 207, Issue 2, 2005, Pages 143-148

  Hoshi, Kunihiko ^a   Kurosawa, Shin ^a   Kato, Masato ^a   Andoh, Kohkichi ^b   Satoh, Daizoh ^c   Kaise, Atsushi ^d  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b SENDAI CITY HOSPITAL   (Japan)

^c Furukawa City Hospital   (Japan)

^d SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

Critically ill patient; Neutrophil elastase inhibitor; Outcome; Sivelestat

Indexed keywords

LEUKOCYTE ELASTASE INHIBITOR; SIVELESTAT; DRUG DERIVATIVE; GLYCINE; LEUKOCYTE ELASTASE; SULFONAMIDE;

ACUTE LUNG INJURY; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; OXYGEN CONCENTRATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ADULT RESPIRATORY DISTRESS SYNDROME; COMPARATIVE STUDY; DRUG ANTAGONISM; HOSPITAL; JAPAN; LENGTH OF STAY; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; GLYCINE; HOSPITALS, UNIVERSITY; HOSPITALS, URBAN; HUMANS; INTENSIVE CARE UNITS; JAPAN; LENGTH OF STAY; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 26944439516     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.207.143     Document Type: Article

References (18)

1. Abel, S.J.C., Finney, S.J., Brett, S.J., Keogh, B.F., Morgan, C.J. & Evans, T.W. (1998) Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax, 53, 292-294.
2. Blackwell, T.S. & Christman, J.W. (1996) Sepsis and cytokines: current status. Br. J. Anaesth., 77, 110-117.
3. Doyle, R.L., Szaflarski, N., Modin, G.W., Wiener-Kronish, J.P. & Matthay, M.A. (1995) Identification of patients with acute lung injury: predictors of mortality. Am. J. Respir. Crit. Care Med., 152, 1818-1824.
4. Ferreira, F.L., Bota, D.P., Bross, A., Melot, C. & Vincent, J.L. (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA, 286, 1754-1758.
5. Kawabata, K., Suzuki, M., Sugitani, M., Imaki, K., Toda, M. & Miyamoto, T. (1991) ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun., 177, 814-820.
6. Le Gall, J.R., Klar, J., Lemeshow, S., Saulnier, F., Alberti, C., Artigas, A. & Teres, D. (1996) The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit: ICU Scoring Group. JAMA, 276, 802-810.
7. Lee, W.L. & Downey, G.P. (2001) Leukocyte elastase. Physiological functions and role in acute lung injury. Am. J. Respir. Crit. Care Med., 164, 896-904.
8. Luhr, O.R., Antonsen, K., Karlsson, M., Aardal, S., Thorsteinsson, A., Frostell, C.G. & Bonde, J. (1999) Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am. J. Respir. Crit. Care Med., 159, 1849-1861.
9. Milberg, J.A., Davis, D.R., Steinberg, K.P. & Hudson, L.D. (1995) Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA, 273, 306-309.
10. Miyazaki, Y., Inoue, T., Kyi, M., Sawada, M., Miyake, S. & Yoshizawa, Y. (1998) Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFα) and activated neutrophils in isolated perfused rabbit lungs. Am. J. Respir. Crit. Care Med., 157, 89-94.
11. Pittet, J.F., Mackersie, R.C., Martin, T.R. & Matthay, M.A. (1997) Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med., 155, 1187-1205.
12. Slutsky, A.S. & Tremblay, L.N. (1998) Multiple system organ failure. Is mechanical ventilation a contributing factor? Am. J. Respir. Crit. Care Med., 157, 1721-1725.
13. Suter, P.M., Suter, S., Girardin, E., Lombard, P.R., Grau, G.E. & Dayer, J.M. (1992) High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis., 145, 1016-1022.
14. Tamakuma, S., Shiba, T., Hirasawa, H., Ogawa, M. & Nakashima, M. (1998) A phase III clinical study of neutrophil elastase inhibitor ONO-5046*Na in SIRS patients. J. Clin. Ther. Med. (Jpn), 14, 289-318.
15. Tate, R.M. & Repine, J.E. (1983) Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 128, 552-559.
16. Ware, L.B. & Matthay, M.A. (2000) The acute respiratory distress syndrome. N. Engl. J. Med., 342, 1334-1349.
17. Zeiher, B.G., Artigas, A., Vincent, J.L., Dmitrienko, A., Jackson, K., Thompson, B.T., Bernard, G. & STRIVE Study Group (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit. Care Med., 32, 1695-1702.
18. Zilberberg, M.D. & Epstein, S.K. (1998) Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am. J. Respir. Crit. Care Med., 157, 1159-1164.